Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Developing novel tetraubiquitin substrates and AlphaLISA technology to provide next generation deubiquitinase assays
substrates 1920
Application Note

Developing novel tetraubiquitin substrates and AlphaLISA technology to provide next generation deubiquitinase assays

Ubiquitination is the modification of cellular proteins with ubiquitin. It is a dynamic and reversible physiological process, affecting the stability and function of proteins, with deubiquitinating enzymes (DUBs) removing attached ubiquitin from proteins.

Most DUB assays currently use fluorescent substrates derived from monoubiquitin, which may not adequately mimic the natural substrates that a DUB acts upon in vivo.

This application note presents novel biochemical DUB assays that use TUBEs to bind to tetraubiquitin substrates of at least three natural linkages. These assays, combined with Revvity’s AlphaLISA™ technology, allow for the measurement of protein interactions and large protein complexes in a no-wash, homogeneous assay. The note includes data illustrating the utility of these assays and demonstrating the specificity of certain DUBs for tetraubiquitin substrates of different linkages.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Download Resource

Developing novel tetraubiquitin substrates and AlphaLISA technology to provide next generation deubiquitinase assays

Download Application Note
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.